GSK and Neptunus form joint venture for the co-development of flu vaccines
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
AstraZeneca to divest Nordic over-the-counter portfolio
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Pfizer withdraws its application to change the marketing authorisation for Viagra
- Details
- Category: Pfizer
![The European Medicines Agency (EMEA) The European Medicines Agency (EMEA)](http://www.worldpharmanews.com/images/stories/logo/emea.gif)
AstraZeneca granted Temporary Restraining Order in PULMICORT RESPULES patent litigation
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of All Infants
- Details
- Category: Sanofi
![sanofi-aventis Group sanofi-aventis Group](http://www.worldpharmanews.com/images/stories/logo/sanofi-avenits.gif)
Pfizer Launches Global Regenerative Medicine Research Unit
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
SEROQUEL XR and SEROQUEL Approved in Europe for New Indications
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
More Pharma News ...
- Tarceva brings new hope to patients with advanced non-small cell lung cancer
- Bayer's Xarelto® Shows Encouraging Results in Patients with Acute Coronary Syndrome
- CRESTOR® is in line with other marketed statins - new data from the JUPITER study
- Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products
- GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies
- AstraZeneca PLC Third Quarter and Nine Months Results 2008
- Novartis to acquire Nektar Therapeutics pulmonary business unit